These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Lin DX; Lang NP; Kadlubar FF Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922 [TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Sadrieh N; Davis CD; Snyderwine EG Cancer Res; 1996 Jun; 56(12):2683-7. PubMed ID: 8665493 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Frandsen H; Alexander J Carcinogenesis; 2000 Jun; 21(6):1197-203. PubMed ID: 10837010 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus. Fretland AJ; Devanaboyina US; Doll MA; Zhao S; Xiao GH; Hein DW Toxicol Sci; 2003 Aug; 74(2):253-9. PubMed ID: 12773763 [TBL] [Abstract][Full Text] [Related]
8. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Liu L; Wagner CR; Hanna PE Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618 [TBL] [Abstract][Full Text] [Related]
9. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1. Ross MK; Pegram RA Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683 [TBL] [Abstract][Full Text] [Related]
10. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359 [TBL] [Abstract][Full Text] [Related]
11. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265 [TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Chou HC; Lang NP; Kadlubar FF Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621 [TBL] [Abstract][Full Text] [Related]
14. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline. Agus C; Ilett KF; Kadlubar FF; Minchin RF Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012 [TBL] [Abstract][Full Text] [Related]
15. N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation. Al-Buheissi SZ; Patel HR; Meinl W; Hewer A; Bryan RL; Glatt H; Miller RA; Phillips DH Pharmacogenet Genomics; 2006 Jun; 16(6):391-9. PubMed ID: 16708048 [TBL] [Abstract][Full Text] [Related]
16. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase. Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236 [TBL] [Abstract][Full Text] [Related]
17. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812 [TBL] [Abstract][Full Text] [Related]
20. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]